Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited Stock
Stocks
600329
CNE000001808
Pharmaceuticals
|
End-of-day quote
Shanghai S.E.
2026-09-30
|
5-day change | 1st Jan Change | ||
| 35.32 CNY | +2.08% |
|
+0.54% | -22.58% |
| Market Cap | 23.49B 3.5B 3.11B 2.91B 2.65B 4.99B 337B 5.06B 35.17B 13.61B 172B 13.14B 12.85B 551B | P/E 2026 * |
26.4x | P/E 2027 * | 22.9x |
|---|---|---|---|---|---|
| Enterprise Value | 23.49B 3.5B 3.11B 2.91B 2.65B 4.99B 337B 5.06B 35.17B 13.61B 172B 13.14B 12.85B 551B | EV / Sales 2026 * |
4.76x | EV / Sales 2027 * | 4.39x |
| Free-Float |
31.71% | Yield 2026 * |
-
| Yield 2027 * | - |
| 1 day | +2.08% | ||
| 1 week | +0.54% | ||
| 1 month | -2.21% | ||
| 3 months | -7.85% | ||
| 6 months | -15.20% | ||
| Current year | -22.58% |
| 1 week | 34.54 |  | 35.5 |
| 1 month | 33.83 | | 36.28 |
| Current year | 33.83 | | 48.2 |
| 1 year | 33.83 | | 50.95 |
| 3 years | 23.4 | | 50.97 |
| 5 years | 17.98 | | 56.26 |
| 10 years | 11.8 | | 56.26 |
| Manager | Title | Age | Since |
|---|---|---|---|
Hong Chen
CEO | Chief Executive Officer | 56 | 2026-09-03 |
Hong Zhou
PRN | Corporate Officer/Principal | 56 | - |
Mai Wang
PRN | Corporate Officer/Principal | 56 | - |
| Director | Title | Age | Since |
|---|---|---|---|
Xiu Mei Guo
BRD | Director/Board Member | 44 | 2018-12-23 |
Mai Wang
BRD | Director/Board Member | 56 | - |
Hong Zhou
BRD | Director/Board Member | 56 | 2019-05-14 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +2.08% | +0.54% | -18.52% | -3.05% | 3.5B | |
| -0.62% | -2.71% | +39.30% | +114.07% | 1,025B | |
| -2.30% | -4.44% | +39.03% | +66.07% | 623B | |
| -0.63% | -1.96% | +6.36% | +74.38% | 459B | |
| -1.03% | -2.82% | +59.56% | +39.69% | 355B | |
| -0.16% | -3.30% | +22.55% | +40.46% | 336B | |
| +0.32% | -1.05% | +13.96% | +26.96% | 270B | |
| +0.08% | -3.79% | -3.04% | +10.28% | 247B | |
| -3.38% | +0.30% | +36.44% | +51.54% | 220B | |
| -1.04% | -1.46% | +32.70% | +96.82% | 183B | |
| Average | -0.68% | -1.72% | +22.83% | +51.72% | 372.17B | |
| Weighted average by Cap. | -0.98% | -2.11% | +30.42% | +69.54% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 4.93B 735M 652M 610M 556M 1.05B 70.72B 1.06B 7.38B 2.86B 36.02B 2.76B 2.7B 116B | 5.35B 797M 708M 662M 603M 1.14B 76.75B 1.15B 8.01B 3.1B 39.09B 2.99B 2.93B 126B |
| Net income | 1.04B 154M 137M 128M 117M 220M 14.86B 223M 1.55B 600M 7.57B 579M 567M 24.31B | 1.18B 176M 157M 147M 134M 251M 16.98B 255M 1.77B 686M 8.65B 662M 648M 27.78B |
| Net Debt | - | - |
Employees
3,890
Sector
Pharmaceuticals
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-09-30 | CN¥35.32 | +2.08% | 1,995,302 |
| 26-09-29 | CN¥34.60 | -1.65% | 1,557,304 |
| 26-09-28 | CN¥35.18 | +0.14% | 1,682,163 |
| 26-09-24 | CN¥35.13 | -0.73% | 1,495,477 |
| 26-09-23 | CN¥35.39 | +0.83% | 1,586,212 |
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
35.32
Average target price
-
Annual profits - Rate of surprise
- Stock Market
- Stocks
- 600329 Stock
Select your edition
All financial news and data tailored to specific country editions
